These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21422415)

  • 1. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options.
    Jaspers HC; Verbist BM; Schoffelen R; Mattijssen V; Slootweg PJ; van der Graaf WT; van Herpen CM
    J Clin Oncol; 2011 Jun; 29(16):e473-6. PubMed ID: 21422415
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathologic study of salivary duct carcinoma and the efficacy of androgen deprivation therapy.
    Yamamoto N; Minami S; Fujii M
    Am J Otolaryngol; 2014; 35(6):731-5. PubMed ID: 25087467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case Report.
    Sheth H; Kumar P; Shreenivas A; Sambath J; Pragya R; Madre C; Athikari N; Khandare H; Peshattiwar V; Datar R; Limaye S
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036229
    [No Abstract]   [Full Text] [Related]  

  • 4. Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy.
    Soper MS; Iganej S; Thompson LD
    Head Neck; 2014 Jan; 36(1):E4-7. PubMed ID: 23720164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.
    Locati LD; Perrone F; Cortelazzi B; Lo Vullo S; Bossi P; Dagrada G; Quattrone P; Bergamini C; Potepan P; Civelli E; Fallai C; Pilotti S; Licitra L
    Head Neck; 2016 May; 38(5):724-31. PubMed ID: 25522335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.
    Weijers JAM; Verhaegh GW; Lassche G; van Engen-van Grunsven ACH; Driessen CML; van Erp NP; Jonker MA; Schalken JA; van Herpen CML
    BMC Cancer; 2024 Sep; 24(1):1174. PubMed ID: 39304797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.
    Fushimi C; Tada Y; Takahashi H; Nagao T; Ojiri H; Masubuchi T; Matsuki T; Miura K; Kawakita D; Hirai H; Hoshino E; Kamata S; Saotome T
    Ann Oncol; 2018 Apr; 29(4):979-984. PubMed ID: 29211833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
    Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
    Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circumscribed salivary duct carcinoma of the palate: a non-threatening variant.
    Ide F; Mishima K; Saito I
    Histopathology; 2004 Jul; 45(1):89-91. PubMed ID: 15228452
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined androgen blockade for salivary gland carcinoma.
    Gourd E
    Lancet Oncol; 2018 Jan; 19(1):e17. PubMed ID: 29233558
    [No Abstract]   [Full Text] [Related]  

  • 11. Complete Response of Metastatic Androgen Receptor-Positive Breast Cancer to Bicalutamide: Case Report and Review of the Literature.
    Arce-Salinas C; Riesco-Martinez MC; Hanna W; Bedard P; Warner E
    J Clin Oncol; 2016 Feb; 34(4):e21-4. PubMed ID: 24888812
    [No Abstract]   [Full Text] [Related]  

  • 12. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
    Yamamoto H; Uryu H; Segawa Y; Tsuneyoshi M
    Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.
    Locati LD; Perrone F; Cortelazzi B; Imbimbo M; Bossi P; Potepan P; Civelli E; Rinaldi G; Quattrone P; Licitra L; Pilotti S
    Cancer Biol Ther; 2014 Jun; 15(6):678-82. PubMed ID: 24618694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bicalutamide].
    Taéron C
    Rev Infirm; 2010 Mar; (158):47-9. PubMed ID: 20383962
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraoral mucin-rich salivary duct carcinoma.
    Henley J; Summerlin DJ; Potter D; Tomich C
    Histopathology; 2005 Oct; 47(4):436-7. PubMed ID: 16178903
    [No Abstract]   [Full Text] [Related]  

  • 16. The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapy.
    Dalgleish AG; Di Palma S; Nathan K; Powell B; Patel N; Fusi A
    Eur J Cancer; 2019 May; 113():14-18. PubMed ID: 30954882
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteoclast-type giant cell tumor of minor salivary gland with mucin-rich salivary duct carcinoma: a case report of unusual histology with immunohistochemical analysis.
    Kusafuka K; Nakamura S; Asano R; Kamijo T; Iida Y; Onistuka T; Nakajima T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):870-7. PubMed ID: 20346712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.
    Kapadia SB; Barnes L
    Mod Pathol; 1998 Nov; 11(11):1033-8. PubMed ID: 9831198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
    Gargano SM; Senarathne W; Feldman R; Florento E; Stafford P; Swensen J; Vranic S; Gatalica Z
    Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review.
    Uijen MJM; Lassche G; van Engen-van Grunsven ACH; Tada Y; Verhaegh GW; Schalken JA; Driessen CML; van Herpen CML
    Cancer Treat Rev; 2020 Sep; 89():102069. PubMed ID: 32717621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.